Depo-Provera Lawsuit Updates
Last updated:
Maybe you heard in June that Pfizer had agreed to settle the Depo-Provera cases, and nothing has reached you since. Thousands of other women are in the same position. The agreement was announced without a dollar figure, without a claims form, and without a date.
Something did change over the summer. The court has now appointed the people who will actually run the settlement. That is the step that turns an announcement into a process.
If you received Depo-Provera injections and were later diagnosed with a meningioma, you can ask for a free case review. Whether that history supports a claim depends on your injection dates, your diagnosis, and the deadline in your state. Pick the situation that fits:
Free and no obligation. Deadlines are set by your state and usually run from the date of diagnosis. Submitting a review request does not create an attorney-client relationship.
Where things stand right now
In June 2026, Pfizer and the lawyers appointed to lead the federal cases said they had reached an agreement in principle to settle the Depo-Provera meningioma claims. The financial terms were not made public. They still have not been.
An agreement in principle means the two sides have agreed to settle and are still writing down what that means. The eligibility rules, the amounts, and the paperwork all get decided at the writing-down stage. None of that has been published yet.
That is still true in October. Three and a half months after the announcement, the court record carries no published eligibility rules and no payment figures. Several litigation trackers report that the two sides signed a written agreement in July and that a registration period may open in November. Pfizer and the lawyers leading the cases have confirmed none of that. Treat a November date you read anywhere as a prediction, not a deadline the court has set.
The first test trial, which had been set for December 2026, was taken off the calendar after the announcement.
If you have a lawyer, the person who can tell you where your own case sits is that lawyer. Nothing on this page changes what they have told you.
The court appointed the settlement team
A settlement of this size is not run by the lawyers who negotiated it. The judge appoints outside professionals to handle the money and the paperwork, and those appointments are public. Over five weeks, Judge M. Casey Rodgers made four of them.
- August 5, Case Management Order 13: BrownGreer was appointed settlement administrator. BrownGreer is the firm that will process claims.
- September 4, Order 15: Matt Garretson of Garretson, LLC was appointed to decide how a supplemental compensation fund gets divided.
- September 4, Order 16: Randall Sansom, an accountant, was appointed to hold and manage the settlement money itself.
- September 4, Order 17: BrownGreer was also appointed to handle liens. Those are the claims that health insurers and Medicare make against a settlement payment.
On September 15, in Order 18, the court opened a separate docket just for settlement business. That keeps the administration paperwork apart from the ongoing litigation. A separate order on August 28 set out how the lawyers who did the shared work on the cases will be paid.
Read together, those five orders say the settlement is being built rather than merely discussed. They do not say when payments start, and they do not say who qualifies.
The claims process is being built, and it is not open yet. Eligibility has not been published, so nobody can tell you today whether a particular case is covered. What a review can do now is look at your injection history, your diagnosis date, and your state deadline.
Check Whether You May QualifyThe science hearing happened, and no ruling has come
Running alongside the settlement is an argument about the science. Pfizer asked the court to rule that the plaintiffs' medical experts should not be allowed to testify that Depo-Provera causes meningioma. The plaintiffs asked the court to exclude Pfizer's experts for the same kind of reason. Both sides finished filing their papers on August 7.
Judge Rodgers held that hearing on September 18, 2026, in Pensacola. Experts testified, the lawyers argued, and the judge said a written order would follow. The transcript was filed on September 24. As of October 4 the court has not ruled. A judge can take weeks or months on a question this size, and there is no deadline for deciding it.
On September 24 the judge canceled the status conferences set for October 16 and November 20. Instead, the lawyers leading the cases and the settlement administrator file written updates, due October 16, November 20 and December 14.
This matters most to anyone whose case may sit outside the settlement. If the court limits what the plaintiffs' experts can say, cases that are not covered by the agreement become much harder to pursue. Whether any particular case is inside or outside the agreement depends on facts that have not been made public yet.
People are still filing
New Depo-Provera cases kept arriving for months after the settlement was announced. The federal court counted 5,830 cases at the start of July. That rose to 6,294 in August, 6,403 in September and 6,412 in October, according to the monthly reports of the Judicial Panel on Multidistrict Litigation.
The pace has slowed sharply. Those four reports added 464 cases, then 109, then 9. A year ago the docket held 806.
Nine new cases in a month is close to a stop. One likely reason is that lawyers are waiting to see the written terms before filing more. That is a decision law firms are making about their own risk, and it says nothing about whether any particular person still has time to act.
One thing that slowing does not tell you is whether filing now still counts. Deadlines in these cases run on state law and usually start from when a person was diagnosed, not from when the settlement was announced.
Waiting for the settlement terms does not pause your deadline. The clock is set by state law and it has been running since diagnosis for most people.
Get a Free Depo-Provera Case ReviewWhat to watch next
- The ruling on the expert evidence from the September 18 hearing, which has not come yet.
- The written settlement terms, which would set out who is eligible and how much.
- A claims process opening, which is what the administrator appointments are preparing for.
- The written status updates due October 16, November 20 and December 14. These replace the in-person conferences and are where settlement progress is most likely to show up first.
This page gets rewritten when those land. The main Depo-Provera page carries the medical and background material that does not change month to month.
How this page fits with the main Depo-Provera page
This page tracks what is happening in court. The main Depo-Provera lawsuits page explains what the cases claim, what a meningioma is, and what records people tend to gather. If you are new to this, start there and come back here for the current status.
Sources
- Judicial Panel on Multidistrict Litigation, monthly distribution of pending MDL dockets, July–October 2026.
- Docket of In re: Depo-Provera (Depot Medroxyprogesterone Acetate) Products Liability Litigation, MDL 3140, U.S. District Court for the Northern District of Florida, case management orders and scheduling orders, August 5 through September 15, 2026.
Find Out If You May Have a Case
If you received Depo-Provera injections and were later diagnosed with a meningioma, a free case review can look at your injection history, your diagnosis date, and your records. It is free, and it can tell you what your situation looks like while the settlement terms are still being written.
Free and no obligation. Lawsuit Center is not a law firm and submitting a request does not create an attorney-client relationship.
